CSIMarket Company Name, Ticker, Competitors, else..
Clover Health Investments Corp   (NASDAQ: CLOV)
Other Ticker:  
 


 

Clover Health Investments Corp

CLOV's Financial Statements and Analysis



Clover Health Investments Corp reported in the second quarter of 2025 net loss per share of $-0.02 compare to earnings per share of $0.01 in the same quarter a year ago a decrease compare to $0.00 realized in previous quarter.


second quarter of 2025
Earnings Per Share Revenues
$ -0.02 $  478 Mill
$-0.03     $+121M     +34.07 %



Clover Health Investments 's Revenue rose by 34.07 % in second quarter of 2025 (Jun 30 2025) year on year, to $478 million and advanced by 3.31 % sequentially.


Clover Health Investments is

More on CLOV's Income Statement



Clover Health Investments in the second quarter of 2025 recorded net loss of $-10.578 million, compare to net income of $7.408 million achieved in II. Quarter a year ago.

Sequentially net loss advanced

More on CLOV's Growth

Clover Health Investments Inventories
CLOV's Cash flow In the second quarter of 2025 company's net cash flow was $33 million, capital expenditures fell by -0.39743.32%, to $-1 millions compare to same quarter a year ago

More on CLOV's Cash flow Statement


Clover Health Investments Corp does not pay out common stock dividend.

In trailing twelve-month period Clover Health Investments Corp payed $ -0.09 cash per share, on a free-cash flow basis .

Book value fell by 0.00 % sequentially to $0.68 per share, 0.00% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value grew to $ 0.67 per share from $ 0.67.

Company issued 11.99 million shares or 2.41 % in Jun 30 2025.


• More on CLOV's Dividends

 Market Capitalization (Millions) 1,257
 Shares Outstanding (Millions) 509
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) 1,608
 Net Income (TTM) (Millions $) -43
 Cash Flow (TTM) (Millions $) -66
 Capital Exp. (TTM) (Millions $) -1
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 552




Clover Health Investments Corp does not pay out common stock dividend.

In trailing twelve-month period Clover Health Investments Corp had negative $ -0.09 cash flow per share, on a free-cash flow basis .

Book value fell by 0.00 % sequentially to $0.68 per share, 0.00% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value grew to $ 0.67 per share from $ 0.67.

Company issued 11.99 million shares or 2.41 % in Jun 30 2025.


• More on CLOV's Balance Sheets

 Market Capitalization (Millions) 1,257
 Shares Outstanding (Millions) 509
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) 1,608
 Net Income (TTM) (Millions $) -43
 Cash Flow (TTM) (Millions $) -66
 Capital Exp. (TTM) (Millions $) -1
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 552
   


  News about Clover Health Investments Corp Earnings

Clover Health's Revenue Plummets in Fiscal First Quarter of 2024



Clover Health Investments Corp (NASDAQ: CLOV) has exhibited concerning financial performance in the first quarter of 2024. Despite a slight improvement in earnings per share and a decrease in the loss per share compared to the previous year, the overall revenue of the company has declined significantly. Additionally, recent executive appointments and stock unit awards may not be sufficient to offset the challenges faced by Clover Health in the highly competitive healthcare industry. This bearish article delves into the company's financials, recent announcements, and potential implications for its future results.
Deteriorating Revenue and Financial Performance:
During the January to March 31...

Struggling Clover Health Investments Corp faces challenges amidst industry growth

The stock market is an ever-changing landscape, with ups and downs that can sometimes leave investors feeling uncertain. However, there are always opportunities to be found, even in the face of disappointing financial reports. One company that has recently disclosed disappointing figures is the Accident and Health Insurance company. Their most recent fiscal period saw a significant decline in revenue, melting down by -43.229% to $510.25 million. Additionally, the Clover Health Investments Corp posted a net deficit per share of $-0.14, compared to $-0.16 in the previous fiscal quarter.
Despite this downturn, it is important to remember that the Clover Health Investments Corp is not alone in facing challen...

CLOV witnesses significant decline in revenue during fiscal period ending September 30, 2023



The Accident and Health Insurance company recently released its financial report for the July to September 2023 period, and the results were nothing short of disappointing. Not only did the company witness a substantial decline in revenue, but its counterpart, Clover Health Investments Corp, also continued to struggle. This bearish article aims to shed light on the concerning figures and delve deeper into the potential reasons behind this negative performance.
Revenue Meltdown and Earnings Shortfall:
Accident and Health Insurance company's Q3 2023 revenues witnessed a staggering decline of -43.738%, plummeting to a meager $482.07 million. This is a significant drop compared to the industry'...

CLOV's Revenue Plunges in Q2 2023, Raises Concerns for Future Prospects



Clover Health Investments Corp, a leading player in the Accident and Health Insurance sector, recently released its financial results for the period ending June 30, 2023. The report highlights significant improvements in the company's financial performance, with a notable decrease in losses per share, improvement in EPS, and a reduction in net shortfall. However, the decline in revenue raises questions about the impact on the company's future prospects.
1. Decreased Losses Per Share and Improved EPS:
One of the positive takeaways from Clover Health's financial results is the significant decrease in losses per share. With -$0.06 per share compared to -$0.22 per share a year ago, the company ...

Clover Health Investments Corp: A Struggle for Investor Returns as Vanishing Deficit Fails to Deliver

Clover Health Investments Corp, a company that specializes in Medicare Advantage plans, has recorded a cumulative net loss of $-336 million during the 12 months ending in the first quarter of 2023. This has resulted in a whopping negative return on investment (ROI) of -83.77%. These abysmal numbers when compared to other financial sector companies indicate that Clover Health Investments Corp has failed miserably in ensuring its investors get a return on their investment.
With 480 other companies in the financial sector recording a higher return on investment, it is clear that Clover Health Investments Corp is struggling. Its re...


Date modified: 2025-08-09T13:39:07+00:00




Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2025 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.